Literature DB >> 18706212

Aberrant expression of Wnt antagonist SFRP1 in pancreatic cancer.

Xian-min Bu1, Cheng-hai Zhao, Xian-wei Dai.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18706212

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


× No keyword cloud information.
  3 in total

1.  Circulating SFRP1 promoter methylation status in gastric adenocarcinoma and esophageal square cell carcinoma.

Authors:  Chang Liu; Nan Li; Heng Lu; Zhengkai Wang; Chunyan Chen; Lin Wu; Jiong Liu; Youke Lu; Fangyu Wang
Journal:  Biomed Rep       Date:  2014-11-17

2.  Diagnostic value of SFRP1 as a favorable predictive and prognostic biomarker in patients with prostate cancer.

Authors:  Lei Zheng; Dongchen Sun; Wentao Fan; Zhiwei Zhang; Quanlin Li; Tao Jiang
Journal:  PLoS One       Date:  2015-02-26       Impact factor: 3.240

3.  MicroRNA-27a-3p Modulates the Wnt/β-Catenin Signaling Pathway to Promote Epithelial-Mesenchymal Transition in Oral Squamous Carcinoma Stem Cells by Targeting SFRP1.

Authors:  Bin Qiao; Bao-Xia He; Jing-Hua Cai; Qian Tao; Alfred King-Yin Lam
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.